These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3241653)

  • 81. The hypothalamic and neurohypophysial vasopressin and oxytocin content under various states of adrenergic transmission in dehydrated and subsequently rehydrated rats.
    Ciosek J; Guzek JW; Morawska J
    Acta Physiol Pol; 1985; 36(4):229-41. PubMed ID: 3019081
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycemia in man.
    Chiodera P; Coiro V
    J Neural Transm Gen Sect; 1991; 83(1-2):121-6. PubMed ID: 1673342
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Daily rhythms in the hormone content of the neurohypophysial system and release of oxytocin and vasopressin in the male rat: effect of constant light.
    Windle RJ; Forsling ML; Guzek JW
    J Endocrinol; 1992 May; 133(2):283-90. PubMed ID: 1613430
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Reversible fatigue of stimulus-secretion coupling in the rat neurohypophysis.
    Bicknell RJ; Brown D; Chapman C; Hancock PD; Leng G
    J Physiol; 1984 Mar; 348():601-13. PubMed ID: 6716296
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Activity-dependent remodeling of chondroitin sulfate proteoglycans extracellular matrix in the hypothalamo-neurohypophysial system.
    Morita S; Oohira A; Miyata S
    Neuroscience; 2010 Apr; 166(4):1068-82. PubMed ID: 20109532
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man.
    Seckl JR; Johnson M; Shakespear C; Lightman SL
    Clin Endocrinol (Oxf); 1988 May; 28(5):509-14. PubMed ID: 3214943
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Differential inhibitory action by morphine on the release of oxytocin and vasopressin from the isolated neural lobe.
    Clarke G; Patrick G
    Neurosci Lett; 1983 Aug; 39(2):175-80. PubMed ID: 6633948
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Osmotic inhibition of neurohypophysial secretion.
    Verbalis JG
    Ann N Y Acad Sci; 1993 Jul; 689():146-60. PubMed ID: 8373011
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study.
    Neumann I; Russell JA; Wolff B; Landgraf R
    Neuroendocrinology; 1991 Dec; 54(6):545-51. PubMed ID: 1784342
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 91. No effect of naloxone on plasma oxytocin in normal men.
    Honer WG; Thompson C; Lightman SL; Williams TD; Checkley SA
    Psychoneuroendocrinology; 1986; 11(2):245-8. PubMed ID: 3749403
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evidence for a direct inhibitory effect of morphine on the secretion of posterior pituitary hormones.
    Lutz-Bucher B; Koch B
    Eur J Pharmacol; 1980 Sep; 66(4):375-8. PubMed ID: 6252017
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Temporal changes in the activity of endogenous opioid mechanisms regulating oxytocin secretion in saline-loaded rats.
    Carter DA; Lightman SL
    Neurosci Lett; 1987 Nov; 82(2):191-5. PubMed ID: 3696493
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Binding sites for atrial natriuretic peptide (ANP) on cultured pituicytes: lack of effect of ANP on release of neurohypophysial hormones in vitro.
    Luckman SM; Bicknell RJ
    Neurosci Lett; 1991 Feb; 123(2):156-9. PubMed ID: 1827519
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of prostaglandin E2 and D2 on the release of vasopressin and oxytocin.
    Hashimoto H; Noto T; Nakajima T
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):9-14. PubMed ID: 2740415
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Opioid control of vasopressin and oxytocin release.
    van Wimersma Greidanus TB; van de Heijning BJ
    Regul Pept; 1993 Apr; 45(1-2):183-6. PubMed ID: 8099753
    [No Abstract]   [Full Text] [Related]  

  • 98. Reflex control of magnocellular vasopressin and oxytocin secretion.
    Cunningham ET; Sawchenko PE
    Trends Neurosci; 1991 Sep; 14(9):406-11. PubMed ID: 1720582
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Lack of effect of opiates on release of vasopressin from isolated rat neurohypophysis.
    Christensen JD; Fjalland B
    Acta Pharmacol Toxicol (Copenh); 1982 Feb; 50(2):113-6. PubMed ID: 7072501
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of methylphenidate on oxytocin and vasopressin levels in pinealectomized rats during light-dark cycle.
    Appenrodt E; Bojanowska E; Janus J; Stempniak B; Guzek JW; Schwarzberg H
    Pharmacol Biochem Behav; 1997 Oct; 58(2):415-9. PubMed ID: 9300600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.